Track the 藥華藥 share price and the full management transaction log of the company, a listed issuer based in Taiwan. Shares trade on the TW market, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €568.9bn. The latest transaction was reported on 31 July 2026 (Gift). Among the most active insiders: 詹青柳. All data is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 藥華藥 Buy (bullish), based on 8 analysts. Average price target: NT$1,312.
Fundamental score
Ranked 6,439 of 29,063 companies
65.6
score / 100
Value
40
Quality
91
FCF yld0.6%
Earn yld0.9%
EV/EBITDA·
ROE23%
Gross mgn89%
Net mgn32%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
藥華藥 es una empresa que cotiza en el XTAI, especializada en el sector farmacéutico. Se enfoca en el desarrollo y comercialización de medicamentos innovadores.